| Name | Tomaralimab |
|---|
| Description | Tomaralimab (OPN-305) is a humanised anti-TLR2 IgG4 monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |